← Back to shop
IC-3 RT — 30 mg research vial

IC-3 RT

Metabolic Research Peptide
In Vitro Research Compound

A single-molecule triple agonist of the GLP-1, GIP, and glucagon receptors — studied for metabolic regulation, appetite signaling, and energy balance in research models.

Size
$145
VISAAMEXDISC•VER Pay zelle ACH

Visa, Mastercard, Amex and Discover · Apple Pay · Zelle · ACH bank transfer

✦ Bundle & Save ✦
3–5 vials
15% off
$123.25
per vial
Best value
6–9 vials
25% off
$108.75
per vial
10+ vials
40% off
$87
per vial
✦ Mix & match any products — the discount tier is set by your total cart vial count (across all products, not per item). Applied automatically, no code needed.

Research Use Only. Product is intended solely for laboratory and research purposes. Not for human or animal consumption. By purchasing, you confirm this product will be used for in vitro research only.

IC-3 RT
Research Compound

Certificate of Analysis

Independently 8× tested by a US ISO/IEC 17025 lab.

8× Testing ISO 17025 Pass
99.92%
Purity
✓ Passed full QC panel
VariantIC-3 RT · 10 mg
Lot #2026-001
Labeled10 mg
Actual10.73 mg
TestedSep 22, 2026
Full QC PanelISO/IEC 17025
  • Purity (HPLC)99.92% ✓
  • Net Peptide Content10.73 mg ●
  • Identity (HPLC-RTM)Retatrutide ✓
  • Heavy Metals (ICP-MS)Not Detected ✓
  • Sterility (PCR)No Growth ✓
  • Endotoxin (USP <85>)0.1 EU/mL ●
  • Fentanyl ScreenNot Detected ✓
✓ passed a specification● reported value, no threshold
View full COA
Issued by ILS Laboratories · COA-2026-G-7HW9
8× Testing ISO 17025 Pass
99.95%
Purity
✓ Passed full QC panel
VariantIC-3 RT · 20 mg
Lot #2026-001
Labeled20 mg
Actual20.73 mg
TestedSep 22, 2026
Full QC PanelISO/IEC 17025
  • Purity (HPLC)99.95% ✓
  • Net Peptide Content20.73 mg ●
  • Identity (HPLC-RTM)Retatrutide ✓
  • Heavy Metals (ICP-MS)Not Detected ✓
  • Sterility (PCR)No Growth ✓
  • Endotoxin (USP <85>)NMT 0.05 EU/mL ●
  • Fentanyl ScreenNot Detected ✓
✓ passed a specification● reported value, no threshold
View full COA
Issued by ILS Laboratories · COA-2026-IDRDCF
8× Testing ISO 17025 Pass
99.93%
Purity
✓ Passed full QC panel
VariantIC-3 RT · 30 mg
Lot #2026-001
Labeled30 mg
Actual30.75 mg
TestedSep 22, 2026
Full QC PanelISO/IEC 17025
  • Purity (HPLC)99.93% ✓
  • Net Peptide Content30.75 mg ●
  • Identity (HPLC-RTM)Retatrutide ✓
  • Heavy Metals (ICP-MS)Not Detected ✓
  • Sterility (PCR)No Growth ✓
  • Endotoxin (USP <85>)NMT 0.05 EU/mL ●
  • Fentanyl ScreenNot Detected ✓
✓ passed a specification● reported value, no threshold
View full COA
Issued by ILS Laboratories · COA-2026-NU9J9C

Batch-specific Certificates of Analysis (COAs) are available, documenting full testing results across all verification protocols for research traceability.

Description

Mechanism & research context

IC-3 RT is a single-molecule triple agonist of the GLP-1, GIP, and glucagon receptors, studied for metabolic regulation, appetite signaling, and energy balance in research models.

GLP-1
Glucagon-like peptide-1 receptor
GIP
Glucose-dependent insulinotropic polypeptide receptor
Glucagon
Glucagon receptor
CAS Number2381089-83-2
Molecular FormulaC₂₂₈H₃₅₀N₄₈O₆₆
Molecular Weight≈ 4,819.6 g/mol
Code NameLY3437943
SequenceY-Aib-QGTFTSDYSI-(αMeLeu)-LDKK-AQ-Aib-AFIEYLLEGGPSSGAPPPS-NH₂
Storage Requirements

Stability Information

Avoid freeze/thaw cycles Protect from light Keep refrigerated
Lyophilized (powder)
−20°C
24+ months
Reconstituted
2–8°C
~30 days
  • Store lyophilized powder vials in the freezer when possible.
  • After reconstitution, refrigerate at 2–8°C and protect from light and heat.
  • Use within a typical research handling window after mixing. Swirl gently — never shake.
  • Use sterile technique during reconstitution.
Research References

Peer-reviewed evidence

Peer-reviewed literature for this triple-hormone-receptor agonist (LY3437943, CAS 2381089-83-2). Each links to its source record.

  1. PubMed — preclinical literature on retatrutide NIH index of peer-reviewed papers — mechanisms, reviews, and preclinical / in-vitro findings
  2. PubChem — chemical identity of retatrutide NCBI compound record: structure, formula, identifiers, and physical properties
  3. Retatrutide reduced pancreatic and lung tumour progression in diet-induced-obese mice npj Metab. Health & Disease · 2025 · DIO mouse models · PMID 40094000
  4. Retatrutide improved renal function and lowered kidney inflammation/fibrosis vs liraglutide and tirzepatide Endocrine · 2025 · db/db mice (diabetic kidney disease) · PMID 39212900
Independent laboratory literature and compound data

Research context only. The papers above are independent published studies, many in laboratory animal models — not medical advice, and not a claim that any applies to this product. Sold strictly for in vitro laboratory research; not for human or animal use.

Terms & Compliance

Terms of sale